83. Addison disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 20 / Drugs : 39 - (DrugBank : 13) / Drug target genes : 6 - Drug target pathways : 18
Addison disease and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 83 | Addison disease | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 6.000 |
| 46 | Malignant rheumatoid arthritis | 6.000 |
| 49 | Systemic lupus erythematosus | 6.000 |
| 53 | Sjogren syndrome | 4.242 |
| 113 | Muscular dystrophy | 4.237 |
| 65 | Primary immunodeficiency | 4.213 |
| 86 | Pulmonary arterial hypertension | 4.208 |
| 96 | Crohn disease | 4.191 |
| 2 | Amyotrophic lateral sclerosis | 4.191 |
| 64 | Thrombotic thrombocytopenic purpura | 3.000 |
| 285 | Fanconi anemia | 2.844 |
| 60 | Aplastic anemia | 2.794 |
| 63 | Idiopathic thrombocytopenic purpura | 2.785 |
| 76 | Pituitary gonadotropin secretion hyperthyroidism | 2.250 |
| 81 | Congenital adrenal hyperplasia | 1.875 |
| 14 | Chronic inflammatory demyelinating polyneuropathy | 1.875 |
| 74 | Prolactin secreting pituitary adenoma | 1.781 |
| 66 | IgA nephropathy | 1.629 |
| 78 | Hypopituitarism | 1.602 |
| 50 | Dermatomyositis | 1.594 |
| 222 | Primary nephrotic syndrome | 1.574 |
| 226 | Interstitial cystitis with Hunners ulcer | 1.570 |
| 84 | Sarcoidosis | 1.555 |
| 299 | Cystic fibrosis | 1.547 |
| 85 | Idiopathic interstitial pneumonia | 1.545 |
| 211 | Hypoplastic left heart syndrome | 1.200 |
| 52 | Mixed connective tissue disease | 1.000 |
| 220 | Rapidly progressive glomerulonephritis | 1.000 |
| 30 | Distal myopathy | 1.000 |